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Abstract Vaginal infections with Candida spp. frequently
occur in women of childbearing age. A small proportion of
these women experience recurrent vulvovaginal candidosis
(RVVC), which is characterized by at least three episodes of
infection in one year. In addition to known risk factors such as
antibiotics, diabetes, or pregnancy, host genetic variation and
inflammatory pathways such as the IL-1/Th17 axis have been
reported to play a substantial role in the pathogenesis of
RVVC. In this study, we assessed a variable number tandem
repeat (VNTR) polymorphism in the NLRP3 gene that en-
codes a component of the inflammasome, processing the pro-
inflammatory cytokines IL-1β and IL-18. A total of 270
RVVC patients and 583 healthy controls were analyzed, and
increased diseases susceptibility was associated with the pres-
ence of the 12/9 genotype. Furthermore, functional studies
demonstrate that IL-1β production at the vaginal surface is
higher in RVVC patients bearing the 12/9 genotype compared
to controls, whereas IL-1Ra levels were decreased and IL-18
levels remained unchanged. These findings suggest that IL-
1β-mediated hyperinflammation conveyed by the NLRP3
gene plays a causal role in the pathogenesis of RVVC and
may identify this pathway as a potential therapeutic target in
the disease.
Introduction
Vulvovaginal candidosis is one of the most frequent infections
in women. Candida spp. in general and C. albicans in partic-
ular are the main cause of this infection. Although not life-
threatening, vulvovaginal candidosis leads to severe discom-
fort, manifested by itching, soreness, rash, and vaginal dis-
charge [1]. Antifungal medication leads to improvement of
the health status in these women, but a small portion of wom-
en continue to experience recurrent vaginal infections with the
fungus, a condition described as recurrent vulvovaginal
candidosis (RVVC). Up to 6–8 % of all women are known
to suffer from RVVC, defined by at least three periods of
vaginal Candida infection per year [2–4]. Although
glucocorticosteroid use, immunosuppressive and antibiotic
therapy, or pregnancy are known risk factors for RVVC, most
patients lack any of these risk factors.
This led to extensive research to identify the (multi-)genic
components predisposing to RVVC susceptibility. Several vari-
ants in genes known to be important in the innate host defense
have been found to be associated with RVVC susceptibility
[5–10]. Awhole range of genetic variations in the NLRP3 gene
have previously been shown to be associated with inflammatory
diseases [11–13]. NLRP3 is part of a multicomplex cytoplasmic
protein platform called inflammasome, which allows the activa-
tion of caspase-1. In turn, caspase-1 cleaves the inactive precur-
sors of interleukin-1 beta (IL-1β) and IL-18 into the biologically
active cytokines. A variable number tandem repeat (VNTR) in
intron 4 (rs74163773) of the NLRP3 gene has previously been
shown to be associated with essential hypertension, as well as
(self-reported history of) vaginal C. albicans infections, and a
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reduction of IL-1β levels in patients suffering from vulvar
vestibulitis syndrome [14, 15]. The present study aims to assess
the role of the VNTR in NLRP3 in patients suffering from
RVVC, as well as to investigate the functional consequences of
this sequence variant on the specific host defense against
C. albicans at the vaginal surface.
Materials and methods
Patients were recruited at the Santa Maria della Misericordia
Medical Center (Perugia, Italy), Wayne State University
School of Medicine (Detroit, MI, USA), Radboud University
Medical Center (Nijmegen, The Netherlands), and Hôpital
Necker (Paris, France). Patients were enrolled during episodes
of acute vaginitis or, if asymptomatic, while receiving mainte-
nance fluconazole therapy. Inclusion criteria for the study were:
otherwise healthy women of at least 18 years of age, diagnosed
with at least three microbiologically documented episodes of
vulvovaginal candidosis within one year, all caused by
C. albicans. Exclusion criteria were use of any immunosuppres-
sive therapy (including steroids), diabetes, pregnancy, or human
immunodeficiency virus (HIV) infection. EDTA venous blood
was collected after obtaining written informed consent. The
study was approved by the Institutional Review Boards of each
of the study centers, and enrollment took place between January
2009 until December 2013. All patients and controls were of
self-reportedWestern European genetic background. To confirm
the genetic homogeneity between samples, we performed mul-
tidimensional scaling (MDS) analysis based on 550,000 single
nucleotide polymorphisms (SNPs) and excluded outliers.
Genotyping
GenomicDNAwas isolated fromETDAvenous blood using the
Gentra Puregene Blood Kit following the manufacturer’s stan-
dard protocol (Qiagen, Venlo, The Netherlands). To amplify the
42-bp VNTR in intron 4 (rs74163773) of the NLRP3 gene, we
used conventional polymerase chain reaction (PCR) with a
primer pair already described by Omi et al. [16]. The resulting
amplicons were subsequently loaded on a 3 % agarose gel to
perform electrophoresis. In our setup, we found five different
alleles, namely 6, 7, 9, 12, and 13, forming the following eight
genotypes: 12/13, 12/12, 12/9, 12/7, 12/6, 9/9, 7/9, and 7/7. The
12 allele was reported to consist of 720 bp, while the 9, 7, and 6
alleles consisted of 594, 510, and 468 bp, respectively [16]. In
addition to this, we observed an additional allele just 42 bp
above the 720-bp 12 allele, named allele 13 (762 bp), in line
with Omi et al. [15]. Differences between patients and controls
in each of the two cohorts were determined using the χ2 statis-
tical analysis.
Cytokine measurement in vaginal fluids
Cervicovaginal samples were collected as described earlier by
Snowhite et al. [17]. In brief, samples were obtained from all
participants during episodes of vaginosis by instilling 3 ml of
sterile saline into the posterior vagina, mixing the saline with
secretions and withdrawing the solution with a 10-ml plastic
syringe. No needles or flushes were used. All vaginal washes
were centrifuged at 12,000×g for 10 min to separate the mucus
from the PBS wash solution shortly after collection, and pellet
fractions were immediately frozen at −80 °C. Cytokine levels in
the lavage fluids were determined by ELISA (R&D Systems).
Data were normalized to total protein levels for each sample
using the Bio-Rad Protein Assay (Bio-Rad, Milan, Italy) and
expressed as log10 pg cytokine/μg total protein).
Results
In our experimental setup, the 42-bp VNTR within intron 4
(rs74163773) of the NLRP3 gene has eight genotypes derived
from five different alleles. The genotypes appear in different
bands on an agarose gel, as shown in Fig. 1. The 12/12 geno-
type was the most prevalent in both control and patient
groups, while the 12/7, 12/9, and 7/7 genotypes were less
prevalent. The 12/13, 12/6, 7/9, and 9/9 genotypes were less
abundant, together accounting for around 15 % of the geno-
types present. Except for the 12/9 genotype, we observed mi-
nor differences comparing the different genotypes between
controls and patients. Nevertheless, significant differences
were seen when we compared the 12/9 genotype between
patients and controls (p-value 0.02) (Table 1).
To investigate the local immune response at the mucosal
surface, we measured inflammasome-dependent cytokine
concentrations in vaginal fluids from either controls or pa-
tients suffering from RVVC. In the analysis, we concentrated
on the 12/12 wild-type genotype and the 12/9 genotype that
was found to be associated with RVVC. IL-1β levels were
higher in the vaginal fluid of RVVC patients compared to
healthy controls. In addition, the 12/9 genotype led to even
higher IL-1β concentrations compared to the 12/12 genotype.
On the other hand, IL-1Ra levels were lower in patients for
both genotypes compared to controls, while those with the 12/
9 genotype had lower concentrations than the patients with the
12/12 genotype. Differences in IL-18 levels did not reveal
significant differences between patients and controls, or be-
tween the RVVC patients with different genotypes (Fig. 2).
Comments
A small study has reported a specific genotype distribution of
a VNTR in the NLRP3 gene in patients with vaginal
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candidosis [14, 16]. If confirmed, this finding would have
important consequences for our understanding of RVVC, as
it would identify cytokines of the IL-1 family as a potential
therapeutic target in the disease. Moreover, a crucial aspect
that needed to be elucidated was whether the risk allele was
associated with a higher or lower cytokine production
capacity at the level of vaginal mucosa. In the present
study, we report that the 12/9 genotype of the rs74163773
VNTR in NLRP3 was associated with recurrent vulvovaginal
infections with C. albicans. Moreover, we report differential
production of the inflammasome-associated cytokines
between patients and controls, with the patients bearing the
risk allele displaying the highest concentration of IL-1β in the
vaginal fluid.
The NLRP3 polymorphism rs74163773 results in 11
genotypes derived from five different alleles. In our setup,
we found only eight of the 11 genotypes, which might be
the result of the low prevalence of the other three geno-
types within the Caucasian population [15]. A previous
study found allele 7 of the NLRP3 gene to be associated
with an increased frequency of RVVC [14]. We were not
able to validate this association; however, we observed
that the 12/9 genotype is significantly associated with an
increased susceptibility to RVVC. Both studies argue thus
that genetic variation in NLRP3 may influence the occur-
rence of vulvovaginal candidosis, but larger future studies
are needed in order to validate this and discern the exact
genotypes involved.
In the vaginal fluid, IL-1β cytokine concentrations were
higher in RVVC patients compared to controls. Furthermore,
carriage of the 12/9 genotype led to an even higher IL-1β
concentration in the vaginal fluid. In line with this, we found
an inverse correlation between IL-1β and IL-1Ra concentra-
tions, with IL-1Ra levels being lower in patient samples and
even further decreased in patients carrying the 12/9 genotype.
An increase in IL-1β levels accompanied by a decreased IL-
1Ra concentration in patients bearing the 12/9 genotype may
lead to a hyperinflammatory state at the vaginal surface [18].
This is in line with the concept that RVVC is likely due to an
inappropriate immunological reaction to Candida growth and
colonization, rather than an immune defect resulting in fungal
overgrowth. There are several important recent findings that
strengthen this conclusion, and propose that the
inflammasome/IL-1β pathway as an important mediator for
the inflammatory reaction:
i. The yeast-to-hyphae germination has been recently shown
to be an important component of vulvovaginal candidosis
pathogenesis [19], and earlier studies demonstrated that
inflammasome/IL-1β activation is a main component of
the hyphae-specific immune response [20].
ii. A recent transcriptome study of murine vaginal
candidosis has identified the NLRP3 inflammasome of a
strong feature of the Candida-induced transcription pro-
file in the vagina [21].
iii. The vaginal fluid showed continuous increases in neutro-
phils and IL-1β of vaginally infected mice during the late
phases of infection, despite a stable fungal load [19].
Fig. 1 Example of different
genotypes of the NLRP3 variable
number tandem repeat (VNTR)
polymorphism on a 3 % agarose
gel. Allele 13: 762 bp, allele 12:
720 bp, allele 9: 594 bp, allele 7:
510 bp, and allele 6: 468 bp;
M= 100-bp marker
Table 1 Genotype distribution of theNLRP3 genotypes for the variable
number tandem repeat (VNTR) in intron 4
NLRP3 genotype Controls RVVC patients p-Value
n % n %
12/12 308 52.83 134 49.63 0.43
12/13 9 1.54 7 2.59 0.44
12/7 134 22.98 62 22.96 1.00
12/9 52 8.92 39 14.44 0.02
12/6 3 0.51 2 0.74 1.00
7/7 45 7.72 11 4.07 0.06
7/9 22 3.77 11 4.07 0.98
9/9 10 1.72 4 1.48 1.00
Total 583 270
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In the present study, we present strong evidence that a
similar overactivation of the inflammasome and IL-1β (but
not IL-18) production is present in patients with RVVC, and
genetic variation in the NLRP3 inflammasome gene has an
important impact on this mechanism.
In conclusion, this study reveals new insights into ge-
netic susceptibility factors that contribute to the develop-
ment of RVVC. Defects in the inflammasome component
NLRP3 are involved in disease development and progres-
sion, most likely by influencing Candida-induced cyto-
kines towards a hyperinflammatory state. It is important
to emphasize that RVVC is a multifactorial disease, in
which not only genetics and the innate immune system,
but also the local microbiome, metabolome as well as
external factors likely play a substantial role. However,
understanding genetic and local defects may increase our
knowledge of the exact pathological mechanisms and
contributes to the development of a better diagnosis and
novel therapies. In this respect, agents targeting IL-1β
overproduction may prove useful in the management of
RVVC.
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Fig. 2 Log10 cytokines (IL-1β, IL-1Ra, and IL-18 in pg cytokine/μg
total protein) in vaginal fluid from recurrent vulvovaginal candidosis
(RVVC) patients and controls. a IL-1β levels between healthy controls
and RVVC patients bearing either the 12/12 (red) or the 12/9 (blue)
genotype. b IL-1Ra levels. c IL-18 levels. Data were analyzed using the
Mann–Whitney U test and * indicates significance of p ≤ 0.05,
**p ≤ 0.01, and ***p ≤ 0.001
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